Healthcare & Life Sciences

Singular Bio

United Statesir.invitae.com/news-and-events/press-releases/press-release-details/2019/Invitae-to-Acquire-Singular-Bio-to-Help-Increase-Access-to-Genetic-Screening-in-Early-Pregnancy/default.aspx

Singular Bio is a Healthcare & Life Sciences startup based in the United States, since acquired, 1 tracked investor.

acquired
View Full ProfileWebsite
acquired
Stage
1
Investors

About Singular Bio

Singular Bio is a company headquartered in the United States. Singular Bio has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Singular Bio developed genetic screening technologies to improve access to early pregnancy genetic testing, and was acquired by Invitae to enhance genetic screening capabilities.

Explore Singular Bio's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

View Startup Profile →View pricing

Other Startups in United States

SingleStoreseries-c-plusSinglePlatformSingleOpsseries-aSingleHopseries-aSingleFileSinecure.aipre-seedSingularity 6series-bSingularity Energyseries-aSinnovaTekSintaviaSionicenergySion Power